Smith & Wesson Brands Earnings Calls
| Release date | Jun 17, 2026 |
| EPS estimate | $0.225 |
| EPS actual | - |
| Revenue estimate | 155.27M |
| Revenue actual | - |
| Expected change | +/- 4.20% |
| Release date | Mar 05, 2026 |
| EPS estimate | $0.0450 |
| EPS actual | $0.0800 |
| EPS Surprise | 77.78% |
| Revenue estimate | 125.588M |
| Revenue actual | 135.709M |
| Revenue Surprise | 8.06% |
| Release date | Dec 04, 2025 |
| EPS estimate | $0.0500 |
| EPS actual | $0.0400 |
| EPS Surprise | -20.00% |
| Revenue estimate | 125.588M |
| Revenue actual | 124.67M |
| Revenue Surprise | -0.731% |
| Release date | Sep 04, 2025 |
| EPS estimate | $0.0200 |
| EPS actual | -$0.0800 |
| EPS Surprise | -500.00% |
| Revenue estimate | 121.246M |
| Revenue actual | 85.077M |
| Revenue Surprise | -29.83% |
Last 4 Quarters for Smith & Wesson Brands
Below you can see how SWBI performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Sep 04, 2025 |
| Price on release | $8.21 |
| EPS estimate | $0.0200 |
| EPS actual | -$0.0800 |
| EPS surprise | -500.00% |
| Date | Price |
|---|---|
| Aug 28, 2025 | $8.07 |
| Aug 29, 2025 | $8.17 |
| Sep 02, 2025 | $8.13 |
| Sep 03, 2025 | $8.02 |
| Sep 04, 2025 | $8.21 |
| Sep 05, 2025 | $8.74 |
| Sep 08, 2025 | $8.84 |
| Sep 09, 2025 | $8.80 |
| Sep 10, 2025 | $9.39 |
| 4 days before | 1.73% |
| 4 days after | 14.37% |
| On release day | 6.46% |
| Change in period | 16.36% |
| Release date | Dec 04, 2025 |
| Price on release | $8.91 |
| EPS estimate | $0.0500 |
| EPS actual | $0.0400 |
| EPS surprise | -20.00% |
| Date | Price |
|---|---|
| Nov 28, 2025 | $8.71 |
| Dec 01, 2025 | $8.68 |
| Dec 02, 2025 | $8.72 |
| Dec 03, 2025 | $8.88 |
| Dec 04, 2025 | $8.91 |
| Dec 05, 2025 | $10.96 |
| Dec 08, 2025 | $10.76 |
| Dec 09, 2025 | $10.71 |
| Dec 10, 2025 | $11.17 |
| 4 days before | 2.30% |
| 4 days after | 25.36% |
| On release day | 23.01% |
| Change in period | 28.24% |
| Release date | Mar 05, 2026 |
| Price on release | $11.79 |
| EPS estimate | $0.0450 |
| EPS actual | $0.0800 |
| EPS surprise | 77.78% |
| Date | Price |
|---|---|
| Feb 27, 2026 | $11.90 |
| Mar 02, 2026 | $12.04 |
| Mar 03, 2026 | $11.86 |
| Mar 04, 2026 | $12.01 |
| Mar 05, 2026 | $11.79 |
| Mar 06, 2026 | $13.99 |
| Mar 09, 2026 | $14.24 |
| Mar 10, 2026 | $14.11 |
| Mar 11, 2026 | $14.01 |
| 4 days before | -0.92% |
| 4 days after | 18.83% |
| On release day | 18.66% |
| Change in period | 17.73% |
| Release date | Jun 17, 2026 |
| Price on release | - |
| EPS estimate | $0.225 |
| EPS actual | - |
| Date | Price |
|---|---|
| May 28, 2026 | $15.22 |
| May 29, 2026 | $15.22 |
| Jun 01, 2026 | $15.14 |
| Jun 02, 2026 | $15.31 |
| Jun 03, 2026 | $14.87 |
Smith & Wesson Brands Earnings Call Transcript Summary of Q1 2026
Smith & Wesson reported better-than-expected Q1 results with net sales of $85.1M and adjusted EBITDA of $8M. Handgun shipments into the sporting goods channel grew ~35% year-over-year despite NICS declines, driven by strong performance across Bodyguard, Shield, and M&P and successful new-product introductions (new products were 37.3% of Q1 sales). Long-gun shipments were down due to mix (down 28.1% into the channel) and lower ASPs sequentially (handguns -4% QoQ, long guns -13% QoQ). Distributor inventory is healthier (units down both sequentially and year-over-year), positioning the company to convert seasonal demand into shipments. Gross margin was 25.9%, pressured by lower production absorption and ~120 bps tariff impact (mainly steel), partially offset by lower promotions and favorable federal excise tax audit outcome. Q1 produced a $3.4M net loss ($0.08 loss per share); cash was $21M with $95M drawn on the credit line. Capital expenditures are expected to be $25–$30M for the year. The Board declared a $0.13 quarterly dividend. Management reiterated a disciplined capital allocation approach (invest, maintain balance sheet, return capital) and highlighted the reopening of the Smith & Wesson Academy to support law enforcement, military and consumer training. Looking ahead, management expects a normal seasonality with Q2 sales growing significantly vs Q1 but roughly 3–5% below Q2 FY2025; Q2 gross margin is expected to be in line with Q1, and operating expenses will be ~20% higher than Q1 (partly due to profit sharing and Academy opening costs). Management remains cautious on full-year macro conditions but confident in maintaining or expanding market share via new products and selective promotions.
Sign In
Buy SWBI